Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Jul;62(1):4–5. doi: 10.1038/bjc.1990.217

Deoxycoformycin in the treatment of mature B-cell malignancies.

C Dearden 1, D Catovsky 1
PMCID: PMC1971740  PMID: 2390480

Full text

PDF
4

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cheson B. D. Current approaches to the chemotherapy of B-cell chronic lymphocytic leukemia: a review. Am J Hematol. 1989 Sep;32(1):72–77. doi: 10.1002/ajh.2830320115. [DOI] [PubMed] [Google Scholar]
  2. Dillman R. O., Mick R., McIntyre O. R. Pentostatin in chronic lymphocytic leukemia: a phase II trial of Cancer and Leukemia group B. J Clin Oncol. 1989 Apr;7(4):433–438. doi: 10.1200/JCO.1989.7.4.433. [DOI] [PubMed] [Google Scholar]
  3. Dissing J., Knudsen B. Adenosine-deaminase deficiency and combined immunodeficiency syndrome. Lancet. 1972 Dec 16;2(7790):1316–1316. doi: 10.1016/s0140-6736(72)92692-x. [DOI] [PubMed] [Google Scholar]
  4. Grem J. L., King S. A., Cheson B. D., Leyland-Jones B., Wittes R. E. Pentostatin in hairy cell leukemia: treatment by the special exception mechanism. J Natl Cancer Inst. 1989 Mar 15;81(6):448–453. doi: 10.1093/jnci/81.6.448. [DOI] [PubMed] [Google Scholar]
  5. Grever M. R., Leiby J. M., Kraut E. H., Wilson H. E., Neidhart J. A., Wall R. L., Balcerzak S. P. Low-dose deoxycoformycin in lymphoid malignancy. J Clin Oncol. 1985 Sep;3(9):1196–1201. doi: 10.1200/JCO.1985.3.9.1196. [DOI] [PubMed] [Google Scholar]
  6. Grever M. R., Siaw M. F., Jacob W. F., Neidhart J. A., Miser J. S., Coleman M. S., Hutton J. J., Balcerzak S. P. The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancy. Blood. 1981 Mar;57(3):406–417. [PubMed] [Google Scholar]
  7. Ho A. D., Ganeshaguru K., Knauf W. U., Dietz G., Trede I., Hunstein W., Hoffbrand A. V. Clinical response to deoxycoformycin in chronic lymphoid neoplasms and biochemical changes in circulating malignant cells in vivo. Blood. 1988 Dec;72(6):1884–1890. [PubMed] [Google Scholar]
  8. Hoffbrand A. V., Ma D. D., Webster A. D. Enzyme patterns in normal lymphocyte subpopulations, lymphoid leukaemias and immunodeficiency syndromes. Clin Haematol. 1982 Oct;11(3):719–741. [PubMed] [Google Scholar]
  9. Johnston J. B., Glazer R. I., Pugh L., Israels L. G. The treatment of hairy-cell leukaemia with 2'-deoxycoformycin. Br J Haematol. 1986 Jul;63(3):525–534. doi: 10.1111/j.1365-2141.1986.tb07530.x. [DOI] [PubMed] [Google Scholar]
  10. Kraut E. H., Bouroncle B. A., Grever M. R. Low-dose deoxycoformycin in the treatment of hairy cell leukemia. Blood. 1986 Nov;68(5):1119–1122. [PubMed] [Google Scholar]
  11. O'Dwyer P. J., Wagner B., Leyland-Jones B., Wittes R. E., Cheson B. D., Hoth D. F. 2'-Deoxycoformycin (pentostatin) for lymphoid malignancies. Rational development of an active new drug. Ann Intern Med. 1988 May;108(5):733–743. doi: 10.7326/0003-4819-108-5-733. [DOI] [PubMed] [Google Scholar]
  12. Piro L. D., Carrera C. J., Beutler E., Carson D. A. 2-Chlorodeoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemia. Blood. 1988 Sep;72(3):1069–1073. [PubMed] [Google Scholar]
  13. Prentice H. G., Smyth J. F., Ganeshaguru K., Wonke B., Bradstock K. F., Janossy G., Goldstone A. H., Hoffbrand A. V. Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemia. Lancet. 1980 Jul 26;2(8187):170–172. doi: 10.1016/s0140-6736(80)90060-4. [DOI] [PubMed] [Google Scholar]
  14. Spiers A. S., Moore D., Cassileth P. A., Harrington D. P., Cummings F. J., Neiman R. S., Bennett J. M., O'Connell M. J. Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin). N Engl J Med. 1987 Apr 2;316(14):825–830. doi: 10.1056/NEJM198704023161401. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES